10-12 December, 2018

London, UK


Antigen-Specific Immune Tolerance Europe 2018 will help you to position your product and services in front of your exact target audience at the most senior level such as the CEOs, CSOs and VPs of the leading biotech companies of this field that will be attending this summit as part of our expert speaker faculty and/or delegate audience.

Furthermore, with the key decision makers of the large pharmaceutical companies also attending this summit, this is truly a one of a kind opportunity to align the future of your company with what these experts foresee as the future of the field of targeted immune tolerance therapies.


Benefit from Market Intelligence
There is a severe unmet medical need as it currently stands to battle autoimmunity. Hear how and where pharmaceutical giants are looking to close this gap to match your solutions accordingly

Raise Brand Awareness
Benefit from pre and post conference exposure to our autoimmunity community and increase market share through unique branding formats.  Also, differentiate your autoimmune target discovery and pre-clinical services from other solution providers

Position Yourself as an Industry Expert
With the emergence of first generation of clinical data, followed by interest shown from large pharma and investors, this meeting is a dedicated platform to put your independent clinical expertise in front of the key decision makers in the field

Meet and Network with Industry Pioneers
With a room full of drug developers looking to see how they can effectively apply targeted immune tolerance solutions to increase clinical success, meet prospective clients during speed networking breaks, 1-2-1 meetings and more informal networking receptions

Generate Commercial Collaborations
Make sure your hottest prospects are in the room and part of the discussion, by having a wish-list of your choice contacted in advance of the event

For further information please don’t hesitate to send us an email.